Advertisement

Topics

Latest "Triangle Pharmaceuticals Incorporated" News Stories

10:51 EDT 18th July 2018 | BioPortfolio

Here are the most relevant search results for "Triangle Pharmaceuticals Incorporated" found in our extensive news archives from over 250 global news sources.

More Information about Triangle Pharmaceuticals Incorporated on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Triangle Pharmaceuticals Incorporated for you to read. Along with our medical data and news we also list Triangle Pharmaceuticals Incorporated Clinical Trials, which are updated daily. BioPortfolio also has a large database of Triangle Pharmaceuticals Incorporated Companies for you to search.

Showing "Triangle Pharmaceuticals Incorporated" News Articles 1–25 of 7,700+

Wednesday 18th July 2018

Altasciences Participates in Clinical Trial for Type 1 Diabetes Mellitus

LAVAL, Quebec, July 18, 2018 (GLOBE NEWSWIRE) -- Altasciences is pleased to have partnered with Xeris Pharmaceuticals, a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use, liquid-stable injectables, on a randomized, controlled, single blind, two-way crossover study to evaluate the efficacy and safety of their inve...


MedSpeed Names Craig Ross as Chief Customer Officer

MedSpeed, a U.S. market-leading provider of healthcare intra-company logistics, names Craig Ross as Chief Customer Officer. In this newly created position, Ross will help continue to enhance the customer experience with a focus on loyalty, satisfaction and retention and focus on supporting MedSpeed’s culture to serve customers and their healthcare communities. ELMHURST, Ill. (PRWEB) July 18, 201...

Global Biosimilars Market Segmented by Product Class and Geography Growth, Trend and Forecast 2018 2023 [Report Updated: 08022018] Prices from USD $1923

The global biosimilar market has been estimated at USD 3474.01 million in 2017. The market is expected to register a CAGR of 43.8% during the forecast period, 2018 to 2023. North America accounted for the largest market share, accounting for approximately 30% of the global market share in 2017, while AsiaPacific region was estimated to register the fastest CAGR through the forecast period, 2018202...


Hikma Acts to Ease Critical Shortage of Pain Medications Needed by US Hospitals and Their Patients

Leading Generic Pharmaceutical Company Increases Manufacturing Capacity to Produce and Release Significant Quantities of Scarce Medicines Hikma Pharmaceuticals PLC (the Hikma Group) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), the multinational generic pharmaceutical company, announced today that its US business has begun releasing significant q...

Stock Yards Bancorp Names John L. Schutte to The Boards of Directors of the Company and Stock Yards Bank & Trust

Stock Yards Bancorp, Inc. (NASDAQ: SYBT), parent company of Stock Yards Bank & Trust Company, with offices in the Louisville, Indianapolis and Cincinnati metropolitan markets, today announced that John L. Schutte has joined the Boards of Directors for both the Company and the Bank. The addition of Schutte, which expands both Boards to 13 directors, con...

Orion Corporation's financial reporting and Annual General Meeting in 2019

ORION CORPORATION          STOCK EXCHANGE RELEASE           18 JULY 2018 at 11.00 EEST                       Orion Corporation's financial reporting and Annual General Meeting in 2019    Orion Corporation will publish its Financial Statement Release 2018 on Wednesday, 6 February 2019. The publication dates of the Interim Reports ...

Tuesday 17th July 2018

Global Vegetable Oil Market Growth, Trends and Forecasts 2018 2023 [Report Updated: 01032018] Prices from USD $4250

The market is estimated to be USD 176.38 billion in 2017 and is expected to register a CAGR of 4.92% during the forecast period 20182023.Global Vegetable Oil Market DynamicsAvailability of broad range of products and wide application in food and industrial sector are driving the market. Developing markets are gaining the attention due to innovation in new flavors and healthy ingredients boost the ...

Eloxx Pharmaceuticals To Present at the 38th Annual Canaccord Genuity Growth Conference

WALTHAM, Mass., July 18, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic fibrosis, cystinosis and other diseases caused by nonsense mutations limiting production of functional proteins, today announced that Chairman and Chief Executive Officer, Robert E...

Global Biosimilars Market Segmented by Product Class and Geography Growth, Trend and Forecast 2018 2023 [Report Updated: 08022018] Prices from USD $4250

The global biosimilar market has been estimated at USD 3474.01 million in 2017. The market is expected to register a CAGR of 43.8% during the forecast period, 2018 to 2023. North America accounted for the largest market share, accounting for approximately 30% of the global market share in 2017, while AsiaPacific region was estimated to register the fastest CAGR through the forecast period, 2018202...

Global Regenerative Medicine Market Segmented by Type of Products, Therapy and Applications Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $1923

The global regenerative medicine market has been estimated to reach USD 4.23 billion in 2023. The market is expected to register a CAGR of 14% during the forecast period 2018 to 2023. North America dominates the market due to the increasing technological advancements. Increasing adoption of stem cell technology Increasing adoption of stem cell technology, increasing prevalence of chronic diseases,...

Global Flavonoid Market Growth, Trends and Forecasts 2018 2023 [Report Updated: 01032018] Prices from USD $4250

The changing lifestyles of consumers and growing demand for beauty health supplements are expected to propel the flavonoids consumption. The global flavonoid market is expected to cross USD 1 billion by 2025. Changing consumer lifestyles and rising demand for beauty health supplements are expected to propel flavonoids consumption over the forecast period 20182023. Phenolic acids, flavonoids, sti...

analytical instruments, life science systems, FT-IR, thermal anaylsis, fluorescence spectroscopy, drug discovery

Manufacturer,of,analytical,instruments,and,life,science,systems,for,biotechnology,pharmaceuticals,drug,discovery,genetics,automated,synthesis,DNA,analysis

20182023 Philippines Vitamin D3 Market Report Status and Outlook [Report Updated: 15062018] Prices from USD $3360

In 2017, the Vitamin D3 market size was xx million USD in Philippines, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.In Philippines market, the top players include Zhejiang Garden Biochemical Hightech Taizhou Hisound Pharmaceutical Kingdomway NHU DSM BASF Zhejiang Medicine FermentaSplit by product types/category, covering Vitamin D3 Oil ...

AcelRx FOPO nets $19mm

AcelRx Pharmaceuticals Inc. (pain drug delivery) netted $19mm in a public offering of 7.3mm shares at $2.75. The company plan...

Teva Pharmaceuticals Aktie: Das Warten auf die Quartalszahlen!

Teva Pharma gehört zu den Big Playern auf dem Pharmamarkt und mischt mit der Tochter Ratiopharm auch auf dem deutschen Markt kräftig mit. Interessant ist das Unternehmen spätestens seitdem Warren B...

J&J beats quarterly expectations on drug sales surge, shares jump

Johnson & Johnson on Tuesday reported better-than-expected second quarter profit as sales of pharmaceuticals surged 20 percent despite a sharp decline in blockbuster arthritis drug Remicade, and its shares rose more than 4 percent.

Antifoaming Agent Market Growth, Trends and Forecasts 2018 2023 [Report Updated: 01032018] Prices from USD $4250

The global antifoaming agent market is expected to register an estimated CAGR of 4.1%, during the forecast period.In March 2017, Evonik introduced new specialty additive for safe food packaging combined with exceptional performance, including Airase 5355, Airase 5655, and Airase 4655 defoamers, as well as a new wetting agent, Surfynol 355 surfactant. All three products were developed specifically...

20182023 Global Mitomycin C Consumption Market Report [Report Updated: 06062018] Prices from USD $4660

In this report, LP Information covers the present scenario with the base year being 2017 and the growth prospects of global Mitomycin C market for 20182023.Mitomycin C market, Mitomycin C is an antibiotic which acts as a doublestranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by way of reductive activation either through low pH or ...

EC grants Akcea and Ionis’s inotersen marketing authorisation

Ionis Pharmaceuticals and its affiliate Akcea Therapeutics have announced their drug Tegsedi (inotersen) has received marketing authorisation approval from the...Read More... The post EC grants Akcea and Ionis’s inotersen marketing authorisation appeared first on Pharmaceutical Technology.

FDA Grants Fast Track Designation to Tonix Pharmaceuticals’ Investigational Treatment for Agitation in Alzheimer’s Disease

NEW YORK, July 16, 2018 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its investigational new drug, TNX-102 SL, for the treatment of agitation in Alzheimer’s disease. The same drug, TNX-102 SL, or Tonmya®*, for the treatment of …

STAT Plus: U.K. health officials make a counteroffer to Vertex for its pricey cystic fibrosis drugs

Seeking to break a stalemate over pricey cystic fibrosis drugs, the U.K.’s National Health Service offered Vertex Pharmaceuticals (VRTX) what it called the “largest ever financial commitment of its type”…

The Official US Launch of Biolon OVD (Ophthalmic Viscosurgical Device) for Use in Cataract Surgery

Amring Pharmaceuticals Inc. (Amring), a generic pharmaceutical company, today announced the release of its latest product, Biolon OVD (Ophthalmic Viscosurgical Device). Amring is excited to offer this device to position itself in the growing ophthalmic market with the introduction of Biolon OVD. Biolon OVD is a fermentation-based, sterile, optical...

Johnson & Johnson's Diabetes Drug Study Stopped Early After Positive Results

NewsJanssen announced that the Phase 3 Credence clinical trial, evaluating the efficacy and safety of Invokana (canagliflozin) for patients with chronic kidney disease (CKD) and type 2 diabetes (T2D), is being stopped early based on the achievement of pre-specified efficacy criteria.

Tegsedi receives European marketing authorisation approval

Akcea Therapeutics and Ionis Pharmaceuticals have announced that Tegsedi (inotersen) has received European marketing authorisation approval for the treatment of stage 1 or stage 2 polyneuropathy in adult patients with hATTR

Sunovion to Launch Take On Tomorrow™ Giving Opportunity with Red Sox Foundation and 7th Annual Community Service Program

Expecting to Reach 25,000 Cumulative Employee Volunteer Hours This Summer, Company Will Mark Milestone by Donating $25,000 to Support Education and Mental Health Initiatives Sunovion Pharmaceuticals Inc. (Sunovion), a partner of the Boston Red Sox, today announced that the Company is continuing its a


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks